Wize Pharma

Wize Pharma EPS Growth

Delisted·Jan 10, 2019

The EPS Growth of Wize Pharma (WIZP) as of Nov 19, 2026 is 30.83 %. In the previous year, EPS Growth was 40.62 % — a change of -24.12% (lower).

EPS Growth

30.83 %

YoY

-24.12%

Last updated:

EPS Growth of Wize Pharma is 2020 30.83 % . EPS Growth of Wize Pharma was 2019 40.62 % . It decreases by -24.12% lower compared to the previous year.

The Wize Pharma EPS Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS Growth
Date
EPS Growth
Jan 1, 2015
-120.33 USD
Jan 1, 2016
63.79 USD
Jan 1, 2017
67.25 USD
Jan 1, 2018
46.31 USD
Jan 1, 2019
40.62 USD
Jan 1, 2020
30.83 USD
The Wize Pharma EPS Growth history
YEAREPS GrowthYoY
30.83 %-24.12%
40.62 %-12.27%
46.31 %-31.15%
67.25 %+5.42%
63.79 %-153.02%
-120.33 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Wize Pharma Stock analysis

What does Wize Pharma do? Wize Pharma Inc. is a leading biopharmaceutical company specializing in the development and marketing of innovative products for the treatment of eye diseases. The company was founded in 1997 and is headquartered in Herzliya Pituach, Israel. It focuses on the research, development, manufacturing, and marketing of eye disease treatments. The company aims to become a leading brand in the field of eye health and offers high-quality services in eye care. Wize Pharma Inc. operates different divisions, with its main divisions being the development and marketing of eye therapeutics, including LO2A and LO2B. LO2A is an innovative therapy for dry eye, while LO2B is an intraoperative formulation used in glaucoma surgery. The company's products provide effective and sustainable solutions for the treatment of eye diseases. Wize Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Wize Pharma stock

EPS Growth of Wize Pharma is 30.83 % in 2020.

On Eulerpool you can find the complete historical development of EPS Growth Wize Pharma since 2006 – with annual values, charts, and detailed analysis.

EPS growth measures the percentage change in earnings per share. It accounts for both profit changes and share count changes.

To evaluate EPS Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EPS Growth.

EPS Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EPS Growth's Wize Pharma historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Wize Pharma

All Key Metrics — Wize Pharma